Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Physical Characteristics And Aerosolization Performance Of Insulin Dry Powders For Inhalation Prepared By A Spray Drying Method

Y. You, M. Zhao, G. Liu, X. Tang
Published 2007 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The objective of this study was to investigate the influence of formulation excipients on the physical characteristics and aerosolization performance of insulin dry powders for inhalation. Insulin dry powders were prepared by a spray drying technique using excipients such as sugars (trehalose, lactose and dextran), mannitol and amino acids (L‐leucine, glycine and threonine). High performance liquid chromatography and the mouse blood glucose method were used for determination of the insulin content. The powder properties were determined and compared by scanning electron microscopy, thermo‐gravimetric analysis and size distribution analysis by a time‐of‐flight technique. The in‐vitro aerosolization behaviour of the powders was assessed with an Aerolizer inhaler using a twin‐stage impinger. Powder yield and moisture absorption were also determined. Results showed that there was no noticeable change in insulin content in any of the formulations by both assay methods. All powders were highly wrinkled, with median aerodynamic diameters of 2–4 μm, and consequently suitable for pulmonary administration. The tapped density was reduced dramatically when glycine was added. The powders containing mannitol, with or without L‐Ieucine, were less sensitive to moisture. The highest respirable fraction of 67.3 ± 1.3% was obtained with the formulation containing L‐leucine, in contrast to formulations containing glycine and threonine, which had a respirable fraction of 11.2 ± 3.9% and 23.5 ± 2.5%, respectively. In addition, powders with good physical properties were achieved by the combination of insulin and trehalose. This study suggests that L‐leucine could be used to enhance the aerosolization behaviour of the insulin dry powders for inhalation, and trehalose could potentially be used as an excipient in the formulations.
This paper references
10.1021/JS980081L
Water vapor sorption studies on the physical stability of a series of spray-dried protein/sugar powders for inhalation.
R. Forbes (1998)
10.1016/J.IJPHARM.2003.09.041
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
Jeffrey O-H Sham (2004)
10.1016/J.IJPHARM.2005.02.004
The influence of dose on the performance of dry powder inhalation systems.
P. Young (2005)
Effect of inlet throat on the correlation between measured fine particle dose and lung deposition
B. Olsson (1996)
Methods and compositions for pulmonary delivery of insulin
J. S. Patton (1995)
10.1023/A:1011983322594
Effect of Spray Drying and Subsequent Processing Conditions on Residual Moisture Content and Physical/Biochemical Stability of Protein Inhalation Powders
Y. Maa (2004)
Effects of L-Leucine on Properties of Interferon Dry Powder Inhalations
Jiang Rong (2005)
10.1016/S0378-5173(01)00945-0
The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
K. Ståhl (2002)
10.1016/S0168-3659(00)00362-X
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
C. Bosquillon (2001)
Effect of amino acids on the dispersion of disodium cromglycate powders
N. Y. K. Chew (2005)
10.1016/J.IJPHARM.2004.07.027
The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
A. R. Najafabadi (2004)
10.1002/JPS.10594
Physical stability of salmon calcitonin spray-dried powders for inhalation.
H. Chan (2004)
10.1016/J.EJPB.2004.03.016
Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.
M. Irngartinger (2004)
10.1021/JS980011E
Activity-stability considerations of trypsinogen during spray drying: effects of sucrose.
S. Tzannis (1999)
10.1002/JPS.2600780311
Protective effect of sucrose on spray drying of oxyhemoglobin.
P. Labrude (1989)
10.2337/DIACARE.28.5.1077
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.
K. Rave (2005)
10.1016/S0301-4622(99)00150-7
Surface properties of aqueous solutions of L-leucine.
J. Glińiski (2000)
10.1111/j.2042-7158.1987.tb03142.x
The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers
G. Hallworth (1987)
10.1016/0168-3659(92)90101-V
In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration
S. Rudt (1992)
10.1016/0378-5173(95)04337-3
Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger
M. Braun (1996)
10.1002/JPS.20426
Effect of amino acids on the dispersion of disodium cromoglycate powders.
N. Chew (2005)
10.1002/(SICI)1097-0290(19981105)60:3<301::AID-BIT5>3.0.CO;2-L
Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation.
Y. Maa (1998)
European Pharmacopoeia, 5 th edn. European Directorate for the Quality of Medicines and Healthcare
European Pharmacopoeia (2005)
10.1016/J.JCONREL.2005.09.004
The influence of formulation components on the aerosolisation properties of spray-dried powders.
Naumana R Rabbani (2005)
10.1089/DIA.2005.7.896
EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin.
S. White (2005)
Aggregation and structural changes in spray dried immunoglobulins
M. Maury (2005)
10.1021/JS9800679
Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody.
H. Costantino (1998)
10.1002/jgm.654
The use of amino acids to enhance the aerosolisation of spray‐dried powders for pulmonary gene therapy
H-Y Li (2005)
10.1111/j.2042-7158.1994.tb03828.x
The Effect of Process and Formulation Variables on the Properties of Spray‐dried β‐Galactosidase
J. Broadhead (1994)
Enhanced drug delivery through reformulating MDIs with HFA propellants – drug deposition and its effect on preclinical and clinical programs
C. Leach (1996)
10.1016/S0169-409X(00)00144-7
Factors affecting short-term and long-term stabilities of proteins.
T. Arakawa (2001)
10.1080/10611860410001659786
Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene Therapy
Hao-ying Li (2003)
10.1002/JPS.10497
Improvement of insulin absorption from intratracheally administrated dry powder prepared by supercritical carbon dioxide process.
H. Todo (2003)



This paper is referenced by
10.1016/j.ijpharm.2013.02.031
Inhaled proteins: challenges and perspectives.
F. Depreter (2013)
10.1016/j.ejps.2019.01.018
D‐leucine microparticles as an excipient to improve the aerosolization performances of dry powders for inhalation
A. Schoubben (2019)
10.3109/10717544.2014.883113
Effects of formulation and operating variables on Zanamivir dry powder inhalation characteristics and aerosolization performance
Y. Yang (2014)
10.1016/j.ijpharm.2017.07.013
Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.
M. Chow (2017)
10.1248/bpb.b15-00791
Safety Evaluation of Dry Powder Formulations by Direct Dispersion onto Air-Liquid Interface Cultured Cell Layer.
Ayumu Asai (2016)
10.1016/j.ejpb.2008.02.010
Stabilization of IgG1 in spray-dried powders for inhalation.
S. Schuele (2008)
10.1016/j.addr.2011.05.003
Lactose characteristics and the generation of the aerosol.
G. Pilcer (2012)
10.1016/j.ijpharm.2014.02.030
Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Seyed Salman Razavi Rohani (2014)
10.3892/etm.2016.3593
Effect of glycerol on sustained insulin release from PVA hydrogels and its application in diabetes therapy
Y. Cai (2016)
10.1080/07373937.2020.1825293
Drying of Vaccines and Biomolecules
B. N. Thorat (2020)
Flowability Evaluation of Dry Powder Inhalation formulations Intended for Nasal Delivery of Betahistine Dihydrochloride
Bissera A. Pilicheva (2015)
10.1016/j.ijpharm.2018.02.026
Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
M. A. Momin (2018)
10.1016/j.ejpb.2008.07.015
Quality by design - Spray drying of insulin intended for inhalation.
M. Maltesen (2008)
Formulation and characterization of liposomal spray dried powders intended for inhalation
Fredrik Kullenberg (2016)
10.1089/jamp.2013.1090
Manufacturing and device options for the delivery of biotherapeutics.
Susan Hoe (2014)
10.1016/j.ijpharm.2018.02.008
Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery.
A. Nieto-Orellana (2018)
Microencapsulated lipid nanoparticles for pulmonary delivery of biopharmaceutical agents
D. P. Gaspar (2017)
10.2174/1389201015666140915150826
Therapeutic nanosystems for oral administration of insulin.
F. A. do Carmo (2014)
10.1016/j.pharma.2018.03.003
Immunoglobulin G particles manufacturing by spray drying process for pressurised metered dose inhaler formulations.
V. Carli (2018)
10.3390/pharmaceutics12121196
Novel Approaches for the Treatment of Pulmonary Tuberculosis
Z. M. Tan (2020)
10.1016/j.ijpharm.2016.08.047
Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.
Z. Wang (2016)
10.1002/pro.2684
Advanced protein formulations
W. Wang (2015)
10.1007/s00894-014-2496-x
A molecular simulation study of the protection of insulin bioactive structure by trehalose
Daixi Li (2014)
10.1016/S0022-3549(15)00189-6
Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
Teresa Jong (2016)
10.1016/j.ejpb.2012.12.022
Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
Dieter Vandenheuvel (2013)
10.1021/acs.molpharmaceut.7b00169
Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.
D. Gaspar (2017)
10.1080/03639045.2019.1609494
Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis
M. A. Momin (2019)
10.1111/j.2042-7158.2012.01521.x
Investigation into the effect of varying l‐leucine concentration on the product characteristics of spray‐dried liposome powders
Kun-Hung Chen (2012)
10.1016/j.ijpharm.2018.04.003
Manipulation of spray‐drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug
M. A. Momin (2018)
10.1016/j.ijpharm.2019.118524
Pulmonary Delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for Treatment of COPD.
A. Mohamed (2019)
10.1016/j.xphs.2017.07.022
Optimization of Acetalated Dextran-Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying.
Z. Wang (2017)
10.1016/j.jconrel.2009.10.010
Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation
D. K. Jensen (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar